Noticias

CVS Health’s first quarter results drew a significant positive market reaction, with performance driven by disciplined cost management, margin expansion, and continued improvement at Aetna. Management credited strong execution in medical cost containment and operational streamlining, particularly within the Health Care Benefits segment, as key factors. CEO David Joyner stated, “We are driving improved results at Aetna, while removing friction for members and providers.” Pharmacy & Consumer Welln

CVS Health (NYSE:CVS) has agreed to sell its Omnicare long-term care pharmacy business to GenieRx Holdings, with the transaction now approved. The company has also introduced CVS Air Response, a drone-enabled healthcare logistics and emergency support network built with SkyfireAI and Thales Aerospace. These moves reflect a refocus on core operations and new delivery channels for pharmacy and healthcare services. For investors tracking NYSE:CVS, these announcements come alongside recent...

Our 24/7 Wall St. price target for CVS Health (NYSE:CVS) is $125.45, pointing to meaningful upside from where shares trade today. The stock closed at $86.86 on May 6, after a 7.65% single-day pop on Q1 earnings. Our model implies 44.43% upside over the next 12 months, and we are issuing a buy rating with ... Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge

CVS Health Corp. (NYSE:CVS) is one of the cheap stocks to buy for the next 10 years. On May 6, CVS Health Corporation reported Q1 2026 results, with total revenues increasing 6.2% year-over-year to $100.4 billion. The company achieved a GAAP diluted EPS of $2.30 and an Adjusted EPS of $2.57, up from $1.41 and […]

Spiking energy prices have pushed inflation to a three-year high of 3.8%. Investors expect price pressures related to the Iran war to ease—one reason the stock market keeps chugging along. Retirees who collect Social Security should get a bigger raise next year.

Investors received two reminders of how well the company did in its first quarter.

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...

NVIDIA, Mastercard and AbbVie headline Zacks' top stock reports, with AI growth, payment trends and drug launches in focus.

With an annual dividend yield of 2.88%, CVS Health Corporation (NYSE:CVS) is included among the 12 Best Blue Chip Dividend Stocks to Buy Now. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness. On May 8, Wells Fargo analyst Stephen Baxter slightly raised […]

​CVS Health Corporation (NYSE:CVS) is one of the Best Undervalued Stocks to Buy Under $100. On May 5, the company announced that its pharmacy benefit arm is updating its commercial formularies effective July 1, 2026. This shift is aimed at lower-cost biosimilars over brand-name reference drugs. ​Management noted that the most prominent change includes replacing […]

The healthcare giant's stock is up after it posted another solid quarter, which showed a big improvement in its bottom line.

More than 20 years after it redefined fast shipping, Amazon is preparing to raise the bar on consumer expectations again by offering to fulfill customers' most urgent product needs in a half-hour or less for an extra fee. The company, which revolutionized online shopping in 2005 with two-day deliveries for Prime members, is rapidly opening small order-processing hubs in dozens of U.S. and foreign cities to cater to shoppers who can't or don't want to wait for cough medicine to relieve flu symptoms or tomatoes for tonight's dinner salad. The ultrafast service, called Amazon Now, first launched in India last June.

CVS Health (NYSE:CVS) expanded its MinuteClinic partnership with Hartford HealthCare to offer adult primary care at all Connecticut locations. Aetna Better Health, a CVS Health business, is providing funding to community health initiatives in Missouri focused on underserved populations. For investors tracking NYSE:CVS, these updates sit alongside a share price of $92.22 and strong recent momentum, with the stock up 12.4% over the past week and 16.2% over the past month. Returns of 15.1%...

CVS Health (CVS) shares have reclaimed their 50-day moving average and are challenging their all-time high around $95 following an eight-month consolidation period. The stock currently maintains a 72% “Buy” technical opinion from Barchart, signaling strong alignment across short, medium, and long-term timeframes. This level for that indicator has been...

CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...

Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year. Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't ...

CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations. On the company’s first-quarter earnings call, David Joyn

CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. Cramer discussed the company’s “great” quarter during the episode, as he said: In Friday night’s game plan, I told you to expect a great quarter from CVS Health, and that’s exactly what we […]

We recently published Jim Cramer Said Sandisk Stock Performance is Befuddling & Discussed These 17 Stocks. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. CVS Health Corporation (NYSE:CVS) continues to be favored by Jim Cramer in the pharmaceutical retailer space. Its shares are up by 30% over the past year […]

To understand whether CVS Health stock might still offer value at around US$87.36, you need to know how that price compares with what the business could be worth using different valuation checks. Recent share price moves have been meaningful, with the stock showing returns of 4.9% over 7 days, 11.7% over 30 days, 9.0% year to date, 33.5% over 1 year, 42.3% over 3 years and 22.4% over 5 years, which can change how investors view both opportunity and risk. Alongside these returns, CVS Health...

CVS Health (NYSE:CVS) is rolling out major biosimilar formulary updates that are expected to affect prescription choices and costs across its pharmacy network. The company is expanding acceptance of WIC benefits statewide in Rhode Island for infant formula, broadening access for eligible families. CVS Health is adding new community partnerships and AI-driven initiatives focused on affordability, nutrition, and local health support. For investors tracking NYSE:CVS, these moves sit alongside...

The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.

Knorr-Bremse (ETR:KBX) opened 2026 with what CEO Marc Llistosella described as the company’s “best first quarter in the past 5 years,” citing margin recovery in the commercial vehicle business and a record order backlog in its rail division. Management also reiterated its full-year guidance, while n

CVS lifted adjusted earnings guidance after first-quarter profit and revenue beat expectations, helped by reserve benefits and stronger Aetna profitability.

Oil prices fell and stocks rose on rising optimism about an end to Middle East hostilities. Iran and the U.S. are working with mediators on a one-page framework to restart negotiations aimed at ending the conflict and opening the Strait of Hormuz, with talks potentially beginning next week in Islamabad. Semiconductor stocks extended their rally.

The ubiquitous pharmacy retailer crushed first-quarter analyst estimates.

Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index increasing